Tag: biotechnology
-
Lilly Buys Precision Cancer Company in $8B Deal
Drug maker Eli Lilly and Company is acquiring a developer of cancer therapies that target specific genetic alterations rather than tumors in the body.
-
Infographic – Nasdaq Biotech Index Recovers
We’ll check in from time to time on the Nasdaq Biotechnology Index that tracks 223 biotech industry stocks.
-
Inhaled Messenger RNA Developed, Tested
An academic-industry team developed an inhaled form of genetic material in nanoscale particles that enables lab mice to safely produce proteins in their lungs.
-
Duchenne Stem Cell Trial Halted
A clinical trial testing stem cell treatments for symptoms of Duchenne muscular dystrophy is on hold after a patient reported a severe reaction.
-
Toxic Neuro Protein Clearance Company Formed
A new enterprise is being formed to develop a device that clears from the nervous system toxic proteins associated with chronic and debilitating neurological disorders.
-
FDA Clears Inhaled Parkinson’s Drug
A drug administered as an inhaled powder to supplement a common treatment for Parkinson’s disease received approval for marketing from the Food and Drug Administration.
-
Eye Drops Reverse Infected Eye Scarring
Eye drops containing a therapeutic protein and applied as a gel, are shown in lab mice to remove scar tissue from the surface of infected or damaged corneas.
-
Nanoscale Bacteria Particles Deliver Cancer Drugs
An engineering lab developed techniques for delivering cancer drugs into tumors in lab cultures and mice with nanoscale polymer particles, aided by a strain of salmonella bacteria.
-
Drug Discovery Start-Up Gains $400M Financing
A 2 year-old company using computational techniques to find protein-targeting drugs raised $400 million in new financing, led by the venture funding arm of Softbank.
-
Nanotech Gene Therapy Company Raises $8.5M in Seed Funds
A start-up company developing nanoscale particles to deliver gene-editing enzymes, including those for Crispr, is raising $8.5 million in its seed funding round.